ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01EA04 | B | Bosutinib - 500mg | 9912/388 | 60719/1 | BOSULIF | 500mg | 28 | Tablet, film coated | Oral | Droguerie Fattal S.A.L. | Pfizer Manufacturing Deutschland GmbH | Germany | L.L | 2.44 | E2 | Pfizer Europe MA EEIG | Belgium | 2/5/2024 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01EA04 | B | Bosutinib - 500mg | 9912 | 60719/1 | BOSULIF | 500mg | 28 | Tablet, film coated | Oral | Droguerie Fattal S.A.L. | Pfizer Manufacturing Deutschland GmbH | Germany | 299,933,996 L.L | 2.44 | E2 | Pfizer Europe MA EEIG | Belgium | 2/5/2024 | 0 |